Skip to main content
Top
Published in: Thrombosis Journal 1/2024

Open Access 01-12-2024 | Protein C Deficiency | Case Report

Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation

Authors: Yunfang Zhang, Bo Wang, Yuxin Bai, Anxin Wang

Published in: Thrombosis Journal | Issue 1/2024

Login to get access

Abstract

Background

Venous thromboembolism(VTE)is a common multifactorial disease. Anticoagulant protein deficiency is the most usual hereditary thrombophilia in the Chinese people, which includes protein C(PC), protein S and antithrombin deficiencies.

Case presentation

A retrospective analysis was conducted on clinical manifestations, laboratory tests, genetic information, and other relevant data of siblings diagnosed with VTE in 2020 at the Department of Pediatrics of Shenzhen Second People’s Hospital. The proband, a 12-year-old female, was admitted to the hospital in December 2020 with a complaint of pain in the left lower limb for four days. The examination found that the PC activity was 53%, and B-ultrasound showed bilateral thrombosis of the great saphenous vein in the thigh segment. The proband’s younger brother, a 10-year-old male, was admitted to the hospital in January 2021 due to right lower limb pain for two weeks. PC activity is 40%. B-ultrasound showed superficial venous thrombosis in the left lower limb and upper limb. Both siblings suffered from thalassemia and underwent splenectomy before recurrent thrombosis occurred. The proband’s mother was asymptomatic, and her PC activity was 45%. Both cases were treated with warfarin anticoagulation, and their symptoms improved. The proband’s mother was found to have a heterozygous mutation at this locus through Sanger sequencing.

Conclusion

Protein C deficiency should be considered for venous thromboembolism in childhood. The heterozygous mutation 1204 A > G in PROC exon 9 in this family is reported for the first time.
Literature
1.
go back to reference Brueckmann M, Hoffmann U, De Rossi L, et al. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes. Cytokine. 2004;26(3):106–13.CrossRefPubMed Brueckmann M, Hoffmann U, De Rossi L, et al. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes. Cytokine. 2004;26(3):106–13.CrossRefPubMed
2.
3.
go back to reference Winther-Larsen A, Kjaergaard AD, Larsen OH, Hvas AM, Nissen PH. Protein C deficiency; PROC gene variants in a Danish population. Thromb Res. 2020;185:153–9.CrossRefPubMed Winther-Larsen A, Kjaergaard AD, Larsen OH, Hvas AM, Nissen PH. Protein C deficiency; PROC gene variants in a Danish population. Thromb Res. 2020;185:153–9.CrossRefPubMed
4.
go back to reference Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.CrossRefPubMedPubMedCentral
5.
go back to reference Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209–20.CrossRefPubMed Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209–20.CrossRefPubMed
6.
go back to reference Wypasek E, Undas A. Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med. 2013;22(4):459–67.PubMed Wypasek E, Undas A. Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med. 2013;22(4):459–67.PubMed
7.
go back to reference Gu Y, Shen W, Zhang L, Zhang J, Ying C. Deficiency of antithrombin and protein C gene in 202 Chinese venous thromboembolism patients. Int J Lab Hematol. 2014;36(2):151–5.CrossRefPubMed Gu Y, Shen W, Zhang L, Zhang J, Ying C. Deficiency of antithrombin and protein C gene in 202 Chinese venous thromboembolism patients. Int J Lab Hematol. 2014;36(2):151–5.CrossRefPubMed
8.
go back to reference Fidalgo T, Martinho P, Salvado R, et al. Familial thrombotic risk based on the genetic background of Protein C Deficiency in a Portuguese study. Eur J Haematol. 2015;95(4):294–307.CrossRefPubMed Fidalgo T, Martinho P, Salvado R, et al. Familial thrombotic risk based on the genetic background of Protein C Deficiency in a Portuguese study. Eur J Haematol. 2015;95(4):294–307.CrossRefPubMed
9.
go back to reference Knoebl PN. Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications. Biologics. 2008;2(2):285–96.PubMedPubMedCentral Knoebl PN. Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications. Biologics. 2008;2(2):285–96.PubMedPubMedCentral
10.
go back to reference Cappellini MD, Musallam KM, Poggiali E, Taher AT. Hypercoagulability in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S20–3.CrossRefPubMed Cappellini MD, Musallam KM, Poggiali E, Taher AT. Hypercoagulability in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S20–3.CrossRefPubMed
11.
12.
go back to reference Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283–92. Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283–92.
13.
go back to reference Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002;126(11):1337–48.CrossRefPubMed Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002;126(11):1337–48.CrossRefPubMed
14.
go back to reference Abd El Mabood S, Fahmy DM, Akef A, El Sallab S. Protein C and Anti-Thrombin-III Deficiency in Children with Beta-Thalassemia. J Hematol. 2018;7(2):62–8.CrossRefPubMedPubMedCentral Abd El Mabood S, Fahmy DM, Akef A, El Sallab S. Protein C and Anti-Thrombin-III Deficiency in Children with Beta-Thalassemia. J Hematol. 2018;7(2):62–8.CrossRefPubMedPubMedCentral
15.
go back to reference Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997;98(1):51–6.CrossRefPubMed Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997;98(1):51–6.CrossRefPubMed
16.
go back to reference A ME, B ZM BNS. Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia. Alexandria J Med. 2012;48(4):283–8.CrossRef A ME, B ZM BNS. Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia. Alexandria J Med. 2012;48(4):283–8.CrossRef
Metadata
Title
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation
Authors
Yunfang Zhang
Bo Wang
Yuxin Bai
Anxin Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2024
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-024-00597-5

Other articles of this Issue 1/2024

Thrombosis Journal 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine